August 2023
189 articles-
Aug 31 · 00:50Biotechnology Daily
Foghorn sinks plans for eye tumor drug after glimpsing phase 1 data
-
Aug 31 · 00:49Biotechnology Daily
Brainwave: Cognition gets ideas about effect of Alzheimer's prospect from midphase data
-
Aug 31 · 00:48Biotechnology Daily
Novartis' cancer drug Jakavi halts cardiac arrhythmias in mice, suggesting repurposing potential
-
Aug 31 · 00:47Biotechnology Daily
Nkarta cell therapy spurs responses in blood cancer, but specific preconditioning needed
-
Aug 31 · 00:46Bio Business News
Novo Nordisk's phase 3 data for hemophilia hopeful fail to shake off Pfizer's shadow
-
Aug 31 · 00:45Bio Business News
ADA: Dexcom plots 2024 launch of sensor for people with Type 2 diabetes who don't use insulin
-
Aug 31 · 00:38Bio Business News
ADA: Tandem strategy chief on the software, hardware updates that'll get late diabetes tech adopters off 'the sidelines'
-
Aug 31 · 00:36Bio Business News
On conference circuit, biotechs lobby for their identity as new IRA drug pricing reforms take hold
-
Aug 30 · 07:19Biotechnology Daily
Women's health biotech to move lead compound into IVF patients after early-stage win
-
Aug 30 · 07:18Biotechnology Daily
Aldeyra's roller coaster month ends with 'positive' phase 2 chronic cough readout
-
Aug 30 · 07:17Biotechnology Daily
Biotech leaders protest 'actively harmful' bans on gender-affirming care
-
Aug 30 · 07:16Biotechnology Daily
Avalo looks to LIGHT as lead asset fails phase 2 asthma trial, dampening stock
-
Aug 30 · 07:15Bio Business News
Illumina begins layoffs in plan to cut more than $100M in expenses this year
-
Aug 30 · 07:14Bio Business News
Lilly's next obesity drug just cut an average of 58 pounds—prompting an all-out phase 3 blitz
-
Aug 30 · 07:12Bio Business News
Meitheal bets there is still life in TNF inhibitors, paying Xentria $45M for lung disease therapy
-
Aug 30 · 07:11Bio Business News
Sanofi's $1.1B eczema drug hits midphase goal, spurring talk of phase 3 and new indications
-
Aug 29 · 01:11Biotechnology Daily
ADA: Gelesis study data position stomach-filling capsule as alternative to GLP-1s for weight loss
-
Aug 29 · 01:09Biotechnology Daily
Let there be light: Scientists report new progress in quest to treat afib with optogenetics
-
Aug 29 · 01:08Biotechnology Daily
After data breadcrumbs, Takeda shows elimination of deadly blood clot attacks for rare disease drug
-
Aug 29 · 01:06Biotechnology Daily
Vertex's diabetes cell therapy spurs insulin production in a half-dozen patients
-
Aug 29 · 01:04Bio Business News
UK's flagging clinical trial sector faces fresh challenge as National Cancer Research Institute set to close
-
Aug 29 · 01:02Bio Business News
MoonLake shines brighter after IL-17 drug wins 'meet or beat' trial against competitors
-
Aug 29 · 01:00Bio Business News
Erytech's merger with Pherecydes reaches the finish line after contentious few months
-
Aug 29 · 00:57Bio Business News
Blackstone injects $140M cash into Sutro Biopharma for Vaxcyte royalties